EQUITY RESEARCH MEMO

DesignPlex Biomedical

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)35/100

DesignPlex Biomedical is a full-service medical device development and contract manufacturing organization (CMO) based in San Diego, California. Founded in 2015, the company specializes in transforming complex concepts into commercial products, focusing on FDA Class II and III devices, particularly in cardiovascular and neuromodulation technologies. Operating under an ISO 13485-compliant quality system, DesignPlex offers end-to-end services from precision prototyping and robust design to GMP manufacturing. Its position as a CMO serving the medtech industry provides recurring revenue opportunities, though the private company does not disclose financials or a pipeline of proprietary products. The growing demand for specialized contract manufacturing in medical devices could support steady growth, but limited public information restricts a full assessment.

Upcoming Catalysts (preview)

  • Q3 2026Execution of new major client contracts for device manufacturing60% success
  • TBDExpansion of manufacturing capacity or facility upgrades50% success
  • Q4 2026Achievement of additional regulatory certifications expanding service scope40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)